During the last three years, we have seen explosive growth in out-licensing of Chinese innovations to global biopharma companies. Novo acquired the leading asset from KBP for $1.3B USD Janssen struck a $245M upfront payment licensing deal with Cellular Biomedicine Group (CBMG) for CAR -T cancer therapies Merck moved forward with a $9.3B ADC deal...

UC Davis Health CoLab brings 350 CEOs and senior leaders in San Francisco to discuss the impact of investments in digital health and AI.

Join us for the 2024 Pre-JPM CTIC 7th Healthcare Summit! This exciting in-person event will take place at the 5th Floor of InterContinental at 888 Howard Street, San Francisco, featuring Bob Langer as our keynote speaker on Sunday, January 7, 2024 ! The Summit is a must-attend gathering for healthcare professionals, entrepreneurs, and innovators. Get ready to dive into the latest trends, advancements, and challenges in...

Attendees will gain an understanding of major policy changes and federal policy debates in 2024. The focus is anticipating the impact of these policy changes on product approval, launch and revenue expectations in the U.S. for in line and pipeline biopharmaceuticals. Topics will include: Inflation Reduction Act Implementation, Anticipated Challenges in IP, Focus on M&A...

The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the fifth annual CERSI Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development. The 2024 CERSI Innovations in Regulatory Science Summit...

Join the Sino-American Pharmaceutical Professionals Association (SAPA) for an exclusive in-person event during the 42nd JP Morgan Healthcare Conference week in San Francisco, California. This is an unparalleled opportunity: Engage with prominent investors, consultants, and legal experts to gain insights on market trends and strategic business guidance. Connect with life science industry leaders and understand...

Healthcare capitalization has a hangover. The boom of investment in 2021 and early 2022 led to some company over-valuations, which, coupled with geopolitical and environmental issues, has led to a major correction in the markets. What’s a company seeking working capital to do? Join EWIB-San Francisco for an informative panel conversation exploring alternative funding opportunities...

ARM’s hybrid 2023 Cell & Gene State of the Industry Briefing attracted over 800+ key stakeholders in the field. This event included ARM’s annual yearly update on the sector’s progress followed by two panel sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year. Who Attends?...

In parallel with the 2024 JP Morgan Healthcare Conference, PCI is honored to welcome a stellar group of innovators to our Innovation @ Penn program in San Francisco on January 8, 2024. This year's panel features an exciting line-up of experts in the field of brain science and neurobiology, including leading luminaries Brian Litt, MD, Perelman...

We are pleased to announce another event in the San Francisco Bay Area, Scientific Speed Networking™ during the JP Morgan Healthcare conference and related events Biotech Showcase, BIO partnering, and RESI. We’ve chosen a location in Mission Bay convenient to Union Square, UCSF, and the many biotechs in that area, Harmonic Brewing Thrive City in the Chase...

Join STAT’s biotech team in San Francisco as they take the stage to help you digest all the biggest stories from the year’s biggest investor conference. Expect several surprise guests to stop by as well, to react to the latest happenings in nearby Union Square at the J.P. Morgan Healthcare Conference. We aim to keep...